PL-5.3 Secondary immunodeficiency with biologic therapies: What every doctor should know
Wednesday December 01, 2021 from 09:35 to 10:05
recording scheduled
Presenter

Christine McCusker, Canada

Associate professor

Pediatrics

Montreal Children's Hospital, McGill University Health Center

Overview

Biological therapies are increasingly used for treatment of malignancies, autoimmunity, and inflammatory diseases involving many different organ systems. It is estimated thatwithin the next 5 years  at least 1/5 patients will recieve biological therapies.  The effects of these drugs on immune functions and the intermediate and long-term potetntial for immuncompromise are now beginning to be appreciated. 

Every physician,with patients in their practice using biologic therapies, needs to be aware of the potential for serious adverse complications associated with these therapies.  In this talk we will highlight the areas of concern and discuss proactive patient managment strategies.

Objectives

As a result of attending this session, participants will be able to:

  • Understand the global effects of biological therapies on immune functioning
  • Identify important intermediate and long term risks
  • Develop management strategies for complication prevention for patients while taking biological therapies and post therapy risk assessment and treatments

Lectures by Christine McCusker


© 2022 McGill Family Physician Refresher Course